Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P W Mallon

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Journal of HIV Therapy|August 17, 2001
Switch therapy studiesP W Mallon
HIV Medicine|December 12, 2001
HIV-associated lipodystrophyP W Mallon, D A Cooper, A Carr
Lancet (London, England)|October 16, 1999
"Something moving in my head"P W Mallon, M Evans, M Hall, et al.
HIV Medicine|March 2, 2019
Two-drug vs. three-drug combinations for HIV-1: Do we have enough data to make the switch?S Moreno, C F Perno, P W Mallon, et al.
HIV Medicine|February 12, 2009
Effect of nucleoside reverse transcriptase inhibitors on CD4 T-cell recovery in HIV-1-infected individuals receiving long-term fully suppressive combination antiretroviral therapyH Byakwaga, J Zhou, K Petoumenos, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 13, 2001
Molecular identification of Acinetobacter sp. in a patient with culture-negative endocarditisP W Mallon, B C Millar, J E Moore, et al.
HIV Medicine|October 28, 2016
Associations between cognitive impairment and patient-reported measures of physical/mental functioning in older people living with HIVJ Underwood, D De Francesco, F A Post, et al.
HIV Medicine|October 6, 2020
Estimated glomerular filtration rate slopes on tenofovir alafenamideF Ibrahim, L Campbell, A C Bailey, et al.
HIV Medicine|March 16, 2019
Level of agreement between frequently used cardiovascular risk calculators in people living with HIVS Dhillon, C A Sabin, J Alagaratnam, et al.
HIV Medicine|October 13, 2020
Antiretroviral treatment outcomes among late HIV presenters initiating treatment with integrase inhibitors or protease inhibitorsG Schuettfort, L Boekenkamp, A Cabello, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of HIV Therapy|August 17, 2001
Switch therapy studiesP W Mallon
HIV Medicine|December 12, 2001
HIV-associated lipodystrophyP W Mallon, D A Cooper, A Carr
Lancet (London, England)|October 16, 1999
"Something moving in my head"P W Mallon, M Evans, M Hall, et al.
HIV Medicine|March 2, 2019
Two-drug vs. three-drug combinations for HIV-1: Do we have enough data to make the switch?S Moreno, C F Perno, P W Mallon, et al.
HIV Medicine|February 12, 2009
Effect of nucleoside reverse transcriptase inhibitors on CD4 T-cell recovery in HIV-1-infected individuals receiving long-term fully suppressive combination antiretroviral therapyH Byakwaga, J Zhou, K Petoumenos, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 13, 2001
Molecular identification of Acinetobacter sp. in a patient with culture-negative endocarditisP W Mallon, B C Millar, J E Moore, et al.
HIV Medicine|October 28, 2016
Associations between cognitive impairment and patient-reported measures of physical/mental functioning in older people living with HIVJ Underwood, D De Francesco, F A Post, et al.
HIV Medicine|October 6, 2020
Estimated glomerular filtration rate slopes on tenofovir alafenamideF Ibrahim, L Campbell, A C Bailey, et al.
HIV Medicine|March 16, 2019
Level of agreement between frequently used cardiovascular risk calculators in people living with HIVS Dhillon, C A Sabin, J Alagaratnam, et al.
HIV Medicine|October 13, 2020
Antiretroviral treatment outcomes among late HIV presenters initiating treatment with integrase inhibitors or protease inhibitorsG Schuettfort, L Boekenkamp, A Cabello, et al.
Pageof 1